PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Large genomic study identifies endometrial cancer subtypes, treatment opportunities

2013-05-02
(Press-News.org) NEW YORK, MAY 1, 2013 – Endometrial tumors can be reclassified into distinct subtypes based partly on their genomic makeup and may respond to targeted drugs already being tested in clinical trials, according to a large-scale genomic analysis led by researchers at Memorial Sloan-Kettering Cancer Center and other centers within The Cancer Genome Atlas (TCGA) Research Network.

Published in the May 2 issue of the journal Nature, the findings may help doctors more accurately diagnose endometrial cancer and choose treatments that will target genomic mutations in women with endometrioid and uterine serous adenocarcinomas, the two most common types of endometrial cancer. The findings could also guide clinical trials and the development of new drugs.

"These findings have an immediate therapeutic application, as patients with endometrial cancer can be tested routinely to see whether they qualify for a targeted therapy clinical trial," said Memorial Sloan-Kettering gynecologic oncologist Douglas A. Levine, MD, corresponding author on the study, principal investigator of Memorial Sloan-Kettering's TCGA Tissue Source Site, and Co-Chair of TCGA's Endometrial Working Group. "The current landscape of treatment for endometrial cancer is quite chaotic, and this research may provide order to that landscape, especially for more-aggressive endometrial cancers."

Endometrial cancer, which forms in the tissues lining the uterus, is the fourth leading type of cancer among women and the eighth leading cause of cancer death. Endometrioid tumors are usually less aggressive, while uterine serous tumors are more aggressive.

There has been little agreement among doctors over the best treatment approach following surgery for patients with a high risk of recurrence, with decisions relying largely on a tumor's pathology. However, it is difficult for pathologists to reliably differentiate high-grade endometrioid tumors from uterine serous tumors.

According to Dr. Levine, incorporating new genomic information into treatment planning could be a great leap forward, helping to make certain that additional therapies are used effectively and only when necessary.

The analysis of 373 endometrial tumors showed that approximately a quarter of high-grade endometrioid tumors have certain types of genomic alterations also found in uterine serous tumors. This suggests that a significant portion of endometrioid tumors should be treated more aggressively after surgery.

Many of the tumors analyzed had mutations in important cancer-related genes and pathways for which targeted therapies are already being tested in clinical trials for other cancers. For example, 84 percent of the tumors have some alteration in the PI3 kinase pathway, which is implicated in many cancers. Additionally, genomic alterations in uterine serous tumors share many features with ovarian serous and triple-negative breast cancers, suggesting opportunity for shared treatments.

Investigators at Memorial Sloan-Kettering are now translating these findings into clinically useful tests that may be applied to ongoing and planned clinical trials.

A project jointly funded by the National Cancer Institute and the National Human Genome Research Institute, TCGA is one of the most comprehensive national efforts to collect and analyze the largest set of tumor samples to date using state-of-the-art genomic and molecular techniques. Memorial Sloan-Kettering currently houses one of TCGA's Genome Data Analysis Centers, led by computational biologist Chris Sander, PhD, biocomputing manager Nikolaus Schultz, PhD, and molecular pathologist Marc Ladanyi, MD. For the endometrial cancer study, Memorial Sloan-Kettering contributed more than 10 percent of all tissue samples analyzed.

###

This research was supported by the National Cancer Institute of the National Institutes of Health (NIH) under award 5U24CA143840-04.

Memorial Sloan-Kettering Cancer Center is the world's oldest and largest private institution devoted to prevention, patient care, research, and education in cancer. Our scientists and clinicians generate innovative approaches to better understand, diagnose, and treat cancer. Memorial Sloan-Kettering specialists are leaders in biomedical research and in translating the latest research to advance the standard of cancer care worldwide. For more information, go to http://www.mskcc.org.

END



ELSE PRESS RELEASES FROM THIS DATE:

Vitamin D: More may not be better

2013-05-02
In recent years, healthy people have been bombarded by stories in the media and on health websites warning about the dangers of too-low vitamin D levels, and urging high doses of supplements to protect against everything from hypertension to hardening of the arteries to diabetes. But new research from Johns Hopkins finds that blood levels of the so-called "sunshine vitamin" higher than the top of the range suggested by the Institute of Medicine confer no additional benefit. This finding, combined with results of a previous study by the same group noting potential harm ...

Troubling levels of toxic metals found in lipstick

2013-05-02
Berkeley — A new analysis of the contents of lipstick and lip gloss may cause you to pause before puckering. Researchers at the University of California, Berkeley's School of Public Health tested 32 different lipsticks and lip glosses commonly found in drugstores and department stores. They detected lead, cadmium, chromium, aluminum and five other metals, some of which were found at levels that could raise potential health concerns. Their findings will be published online Thursday, May 2, in the journal Environmental Health Perspectives. Prior studies also have found ...

Weight loss surgery safe and effective for an expanded group of patients

2013-05-02
The LAP-BAND® weight loss procedure is safe and effective in an expanded group of patients, not just in people who are morbidly obese. This conclusion is reported in a new study published in the scientific journal Obesity. The findings indicate that the procedure may help to intervene before obesity becomes life threatening to patients. In 2001 the LAP-BAND® adjustable gastric banding system (LAGB) was approved by the FDA as weight loss procedure for patients with a body mass index (BMI) of 40 kg/m2 or higher and for patients with a BMI of at least 35 with an obesity-related ...

Children with milk allergy may be 'allergic to school'

2013-05-02
ARLINGTON HEIGHTS, ILL. (May 2, 2013) – Many of today's school teachers opt for dustless chalk to keep hands and classrooms clean. But according to a study published in the May issue of Annals of Allergy, Asthma & Immunology, the scientific journal of the American College of Allergy, Asthma and Immunology (ACAAI), this choice in chalk may cause allergy and asthma symptoms in students that have a milk allergy. Casein, a milk protein, is often used in low-powder chalk. When milk allergic children inhale chalk particles containing casein, life-threatening asthma attacks ...

Third time's the charm for California's Three Feet for Safety Act?

2013-05-02
Third time's the charm for California's Three Feet for Safety Act? Article provided by Hanasab & Zolekhian, LLP Visit us at http://www.hzpersonalinjury.com As Californians increasingly bike to work or hop on a bicycle for exercise, drivers and bicyclists must learn to share the road safely. Part of safe driving includes making sure the bicyclist has enough room to ride and is not in danger of being clipped by a passing car or running into trouble along curbs, gutters or parked vehicles. After being vetoed twice in previous years, legislation has been proposed ...

New federal agency standards to limit behind-the-wheel distractions

2013-05-02
New federal agency standards to limit behind-the-wheel distractions Article provided by Lynch, Traub, Keefe & Errante, P.C. Visit us at http://www.ltke.com Connecticut recently passed one of the broadest cellphone bans in the country. But according to the National Highway Traffic Safety Administration cellphones and other in-vehicle technology continue to cause driver distractions and Connecticut car accidents. The federal agency recently released new voluntary guidelines for automakers related to in-vehicle technology. The new guidelines discourage automakers ...

Potential overhaul of New York's workers' compensation

2013-05-02
Potential overhaul of New York's workers' compensation Article provided by The Law Offices of Sher, Herman, Bellone & Tipograph Visit us at http://www.newyorkworkerscompensationlawattorney.com In January Governor Cuomo introduced a proposed budget bill, part of which aims at reforming several elements of the workers' compensation system. According to the Insurance Journal, the New York Compensation Insurance Rating Board estimates that Cuomo's bill will increase future workers compensation loss costs by anywhere between 4.4 and 5.3 percent. Moreover, the NYCIRB ...

Traffic fatalities up in US in 2012; down in Wisconsin in 2013

2013-05-02
Traffic fatalities up in US in 2012; down in Wisconsin in 2013 Article provided by The Law Offices of Robert A. Levine Visit us at http://www.relevinelaw.com After almost a decade of declining numbers, preliminary reports from the National Safety Council have shown that the number of traffic fatalities rose in 2012 across the country. According to the NSC data, 36,200 people were killed in motor vehicle accidents during 2012. The NSC predictions represent a 5 percent increase from the number of traffic fatalities in 2011. The number of people killed in auto accidents ...

Study shows private airplane accidents result in most fatalities

2013-05-02
Study shows private airplane accidents result in most fatalities Article provided by Kreindler & Kreindler LLP Visit us at http://www.kreindler.com Recently the Federal Aviation Administration decided to eliminate funding for 149 air traffic control towers. Given this decision's tremendous safety impact, airport operators have brought suit in a federal court to prevent the FAA's plan from being implement. According to ABC News, safety is still one of the FAA's main concerns, and that the closing of the air traffic controllers is necessary in order to eliminate ...

Tread carefully when using social media for business purposes

2013-05-02
Tread carefully when using social media for business purposes Article provided by Millstone, Peterson & Watts, LLP Visit us at http://www.mpwlaw.net Early in April, the Securities and Exchange Commission (S.E.C.) released new guidelines regarding the use of social media by businesses. The guidelines address disclosures by companies who use social networks including such outlets as: -Facebook -Twitter -Blogs -LinkedIn -Google Plus+ -Hootsuite -- a social media management system The newly established guidelines were a result of some perceived missteps ...

LAST 30 PRESS RELEASES:

Cal Poly’s fifth Climate Solutions Now conference to take place Feb. 23-27

Mask-wearing during COVID-19 linked to reduced air pollution–triggered heart attack risk in Japan

Achieving cross-coupling reactions of fatty amide reduction radicals via iridium-photorelay catalysis and other strategies

Shorter may be sweeter: Study finds 15-second health ads can curb junk food cravings

Family relationships identified in Stone Age graves on Gotland

Effectiveness of exercise to ease osteoarthritis symptoms likely minimal and transient

Cost of copper must rise double to meet basic copper needs

A gel for wounds that won’t heal

Iron, carbon, and the art of toxic cleanup

Organic soil amendments work together to help sandy soils hold water longer, study finds

Hidden carbon in mangrove soils may play a larger role in climate regulation than previously thought

Weight-loss wonder pills prompt scrutiny of key ingredient

Nonprofit leader Diane Dodge to receive 2026 Penn Nursing Renfield Foundation Award for Global Women’s Health

Maternal smoking during pregnancy may be linked to higher blood pressure in children, NIH study finds

New Lund model aims to shorten the path to life-saving cell and gene therapies

Researchers create ultra-stretchable, liquid-repellent materials via laser ablation

Combining AI with OCT shows potential for detecting lipid-rich plaques in coronary arteries

SeaCast revolutionizes Mediterranean Sea forecasting with AI-powered speed and accuracy

JMIR Publications’ JMIR Bioinformatics and Biotechnology invites submissions on Bridging Data, AI, and Innovation to Transform Health

Honey bees navigate more precisely than previously thought

Air pollution may directly contribute to Alzheimer’s disease

Study finds early imaging after pediatric UTIs may do more harm than good

UC San Diego Health joins national research for maternal-fetal care

New biomarker predicts chemotherapy response in triple-negative breast cancer

Treatment algorithms featured in Brain Trauma Foundation’s update of guidelines for care of patients with penetrating traumatic brain injury

Over 40% of musicians experience tinnitus; hearing loss and hyperacusis also significantly elevated

Artificial intelligence predicts colorectal cancer risk in ulcerative colitis patients

Mayo Clinic installs first magnetic nanoparticle hyperthermia system for cancer research in the US

Calibr-Skaggs and Kainomyx launch collaboration to pioneer novel malaria treatments

JAX-NYSCF Collaborative and GSK announce collaboration to advance translational models for neurodegenerative disease research

[Press-News.org] Large genomic study identifies endometrial cancer subtypes, treatment opportunities